We are live on ! Find out more
FBIO icon

Fortress Biotech

53 hedge funds and large institutions have $15M invested in Fortress Biotech in 2026 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more capital inflows, than outflows

Capital inflows: $6.41M | Capital outflows: $4.23M

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

0% more funds holding

Funds holding: 53 → 53 (0)

1.39% less ownership

Funds ownership: 18.65% → 17.27% (-1.4%)

35% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 17

49% less call options, than puts

Call options by funds: $585K | Put options by funds: $1.16M

Holders
53
Holders Change
–
Holders Change %
0%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
11
Reduced
17
Closed
11
Calls
$585​K
Puts
$1.16​M
Net Calls
-⁠$570​K
Net Calls Change
+$353​K

FBIO Hedge Fund Activity: Q1 2026 in Review

53 of the 8,243 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q1 2026, worth a combined $15M — down 30% from $21.2M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new FBIO positions and 11 closed out — a net gain of 2 holders — while 11 added to existing stakes and 17 trimmed.

The largest buyer was GSA Capital Partners, adding an estimated $741K. The largest seller was Summit Financial, cutting an estimated $1.42M.

  • 53 institutional investors held Fortress Biotech (FBIO) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $15M of Fortress Biotech stock for Q1 2026, down 30% quarter-over-quarter.
  • 13 funds opened new Fortress Biotech positions in Q1 2026 and 11 closed out, a net change of +2 holders.
  • The largest Fortress Biotech buyer in Q1 2026 was GSA Capital Partners, an estimated $741K added.
  • The largest Fortress Biotech seller in Q1 2026 was Summit Financial, an estimated $1.42M sold.

Based on aggregated 13F filings for Q1 2026.